Medical Care
Global Biomarker Technology Market Research Report 2025
- May 05, 25
- ID: 228320
- Pages: 77
- Figures: 77
- Views: 6
The global market for Biomarker Technology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Biomarker Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biomarker Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Biomarker Technology in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biomarker Technology include Abbott Laboratories, Quanterix, Bio-Rad Laboratories, Epigenomics, Agilent Technologies, Johnson & Johnson, Qiagen, Roche Holding, Siemens Healthcare, Myriad Genetics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomarker Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Technology.
The Biomarker Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomarker Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Quanterix
Bio-Rad Laboratories
Epigenomics
Agilent Technologies
Johnson & Johnson
Qiagen
Roche Holding
Siemens Healthcare
Myriad Genetics
Segment by Type
Polymerase Chain Reaction(PCR)
Next Generation Sequencing(NGS)
Immunoassay
Others
Segment by Application
Cancer
Infectious Diseases
Auoimmune Disorders
Cardiovascular Disorders
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Biomarker Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biomarker Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Biomarker Technology in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biomarker Technology include Abbott Laboratories, Quanterix, Bio-Rad Laboratories, Epigenomics, Agilent Technologies, Johnson & Johnson, Qiagen, Roche Holding, Siemens Healthcare, Myriad Genetics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomarker Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Technology.
The Biomarker Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomarker Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Quanterix
Bio-Rad Laboratories
Epigenomics
Agilent Technologies
Johnson & Johnson
Qiagen
Roche Holding
Siemens Healthcare
Myriad Genetics
Segment by Type
Polymerase Chain Reaction(PCR)
Next Generation Sequencing(NGS)
Immunoassay
Others
Segment by Application
Cancer
Infectious Diseases
Auoimmune Disorders
Cardiovascular Disorders
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction(PCR)
1.2.3 Next Generation Sequencing(NGS)
1.2.4 Immunoassay
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biomarker Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Auoimmune Disorders
1.3.5 Cardiovascular Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarker Technology Market Perspective (2020-2031)
2.2 Global Biomarker Technology Growth Trends by Region
2.2.1 Global Biomarker Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biomarker Technology Historic Market Size by Region (2020-2025)
2.2.3 Biomarker Technology Forecasted Market Size by Region (2026-2031)
2.3 Biomarker Technology Market Dynamics
2.3.1 Biomarker Technology Industry Trends
2.3.2 Biomarker Technology Market Drivers
2.3.3 Biomarker Technology Market Challenges
2.3.4 Biomarker Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarker Technology Players by Revenue
3.1.1 Global Top Biomarker Technology Players by Revenue (2020-2025)
3.1.2 Global Biomarker Technology Revenue Market Share by Players (2020-2025)
3.2 Global Biomarker Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biomarker Technology Revenue
3.4 Global Biomarker Technology Market Concentration Ratio
3.4.1 Global Biomarker Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Technology Revenue in 2024
3.5 Global Key Players of Biomarker Technology Head office and Area Served
3.6 Global Key Players of Biomarker Technology, Product and Application
3.7 Global Key Players of Biomarker Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker Technology Breakdown Data by Type
4.1 Global Biomarker Technology Historic Market Size by Type (2020-2025)
4.2 Global Biomarker Technology Forecasted Market Size by Type (2026-2031)
5 Biomarker Technology Breakdown Data by Application
5.1 Global Biomarker Technology Historic Market Size by Application (2020-2025)
5.2 Global Biomarker Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biomarker Technology Market Size (2020-2031)
6.2 North America Biomarker Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biomarker Technology Market Size by Country (2020-2025)
6.4 North America Biomarker Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomarker Technology Market Size (2020-2031)
7.2 Europe Biomarker Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biomarker Technology Market Size by Country (2020-2025)
7.4 Europe Biomarker Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Technology Market Size (2020-2031)
8.2 Asia-Pacific Biomarker Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biomarker Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Biomarker Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomarker Technology Market Size (2020-2031)
9.2 Latin America Biomarker Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biomarker Technology Market Size by Country (2020-2025)
9.4 Latin America Biomarker Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Technology Market Size (2020-2031)
10.2 Middle East & Africa Biomarker Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biomarker Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Biomarker Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Biomarker Technology Introduction
11.1.4 Abbott Laboratories Revenue in Biomarker Technology Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Quanterix
11.2.1 Quanterix Company Details
11.2.2 Quanterix Business Overview
11.2.3 Quanterix Biomarker Technology Introduction
11.2.4 Quanterix Revenue in Biomarker Technology Business (2020-2025)
11.2.5 Quanterix Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Biomarker Technology Introduction
11.3.4 Bio-Rad Laboratories Revenue in Biomarker Technology Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Epigenomics
11.4.1 Epigenomics Company Details
11.4.2 Epigenomics Business Overview
11.4.3 Epigenomics Biomarker Technology Introduction
11.4.4 Epigenomics Revenue in Biomarker Technology Business (2020-2025)
11.4.5 Epigenomics Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Biomarker Technology Introduction
11.5.4 Agilent Technologies Revenue in Biomarker Technology Business (2020-2025)
11.5.5 Agilent Technologies Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Biomarker Technology Introduction
11.6.4 Johnson & Johnson Revenue in Biomarker Technology Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Biomarker Technology Introduction
11.7.4 Qiagen Revenue in Biomarker Technology Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 Roche Holding
11.8.1 Roche Holding Company Details
11.8.2 Roche Holding Business Overview
11.8.3 Roche Holding Biomarker Technology Introduction
11.8.4 Roche Holding Revenue in Biomarker Technology Business (2020-2025)
11.8.5 Roche Holding Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Details
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare Biomarker Technology Introduction
11.9.4 Siemens Healthcare Revenue in Biomarker Technology Business (2020-2025)
11.9.5 Siemens Healthcare Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Details
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Biomarker Technology Introduction
11.10.4 Myriad Genetics Revenue in Biomarker Technology Business (2020-2025)
11.10.5 Myriad Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction(PCR)
1.2.3 Next Generation Sequencing(NGS)
1.2.4 Immunoassay
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biomarker Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Auoimmune Disorders
1.3.5 Cardiovascular Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarker Technology Market Perspective (2020-2031)
2.2 Global Biomarker Technology Growth Trends by Region
2.2.1 Global Biomarker Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biomarker Technology Historic Market Size by Region (2020-2025)
2.2.3 Biomarker Technology Forecasted Market Size by Region (2026-2031)
2.3 Biomarker Technology Market Dynamics
2.3.1 Biomarker Technology Industry Trends
2.3.2 Biomarker Technology Market Drivers
2.3.3 Biomarker Technology Market Challenges
2.3.4 Biomarker Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarker Technology Players by Revenue
3.1.1 Global Top Biomarker Technology Players by Revenue (2020-2025)
3.1.2 Global Biomarker Technology Revenue Market Share by Players (2020-2025)
3.2 Global Biomarker Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biomarker Technology Revenue
3.4 Global Biomarker Technology Market Concentration Ratio
3.4.1 Global Biomarker Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Technology Revenue in 2024
3.5 Global Key Players of Biomarker Technology Head office and Area Served
3.6 Global Key Players of Biomarker Technology, Product and Application
3.7 Global Key Players of Biomarker Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker Technology Breakdown Data by Type
4.1 Global Biomarker Technology Historic Market Size by Type (2020-2025)
4.2 Global Biomarker Technology Forecasted Market Size by Type (2026-2031)
5 Biomarker Technology Breakdown Data by Application
5.1 Global Biomarker Technology Historic Market Size by Application (2020-2025)
5.2 Global Biomarker Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biomarker Technology Market Size (2020-2031)
6.2 North America Biomarker Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biomarker Technology Market Size by Country (2020-2025)
6.4 North America Biomarker Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomarker Technology Market Size (2020-2031)
7.2 Europe Biomarker Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biomarker Technology Market Size by Country (2020-2025)
7.4 Europe Biomarker Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Technology Market Size (2020-2031)
8.2 Asia-Pacific Biomarker Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biomarker Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Biomarker Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomarker Technology Market Size (2020-2031)
9.2 Latin America Biomarker Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biomarker Technology Market Size by Country (2020-2025)
9.4 Latin America Biomarker Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Technology Market Size (2020-2031)
10.2 Middle East & Africa Biomarker Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biomarker Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Biomarker Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Biomarker Technology Introduction
11.1.4 Abbott Laboratories Revenue in Biomarker Technology Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Quanterix
11.2.1 Quanterix Company Details
11.2.2 Quanterix Business Overview
11.2.3 Quanterix Biomarker Technology Introduction
11.2.4 Quanterix Revenue in Biomarker Technology Business (2020-2025)
11.2.5 Quanterix Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Biomarker Technology Introduction
11.3.4 Bio-Rad Laboratories Revenue in Biomarker Technology Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Epigenomics
11.4.1 Epigenomics Company Details
11.4.2 Epigenomics Business Overview
11.4.3 Epigenomics Biomarker Technology Introduction
11.4.4 Epigenomics Revenue in Biomarker Technology Business (2020-2025)
11.4.5 Epigenomics Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Biomarker Technology Introduction
11.5.4 Agilent Technologies Revenue in Biomarker Technology Business (2020-2025)
11.5.5 Agilent Technologies Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Biomarker Technology Introduction
11.6.4 Johnson & Johnson Revenue in Biomarker Technology Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Biomarker Technology Introduction
11.7.4 Qiagen Revenue in Biomarker Technology Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 Roche Holding
11.8.1 Roche Holding Company Details
11.8.2 Roche Holding Business Overview
11.8.3 Roche Holding Biomarker Technology Introduction
11.8.4 Roche Holding Revenue in Biomarker Technology Business (2020-2025)
11.8.5 Roche Holding Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Details
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare Biomarker Technology Introduction
11.9.4 Siemens Healthcare Revenue in Biomarker Technology Business (2020-2025)
11.9.5 Siemens Healthcare Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Details
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Biomarker Technology Introduction
11.10.4 Myriad Genetics Revenue in Biomarker Technology Business (2020-2025)
11.10.5 Myriad Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biomarker Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Polymerase Chain Reaction(PCR)
Table 3. Key Players of Next Generation Sequencing(NGS)
Table 4. Key Players of Immunoassay
Table 5. Key Players of Others
Table 6. Global Biomarker Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biomarker Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biomarker Technology Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biomarker Technology Market Share by Region (2020-2025)
Table 10. Global Biomarker Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biomarker Technology Market Share by Region (2026-2031)
Table 12. Biomarker Technology Market Trends
Table 13. Biomarker Technology Market Drivers
Table 14. Biomarker Technology Market Challenges
Table 15. Biomarker Technology Market Restraints
Table 16. Global Biomarker Technology Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biomarker Technology Market Share by Players (2020-2025)
Table 18. Global Top Biomarker Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Technology as of 2024)
Table 19. Ranking of Global Top Biomarker Technology Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biomarker Technology Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biomarker Technology, Headquarters and Area Served
Table 22. Global Key Players of Biomarker Technology, Product and Application
Table 23. Global Key Players of Biomarker Technology, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biomarker Technology Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biomarker Technology Revenue Market Share by Type (2020-2025)
Table 27. Global Biomarker Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biomarker Technology Revenue Market Share by Type (2026-2031)
Table 29. Global Biomarker Technology Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biomarker Technology Revenue Market Share by Application (2020-2025)
Table 31. Global Biomarker Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biomarker Technology Revenue Market Share by Application (2026-2031)
Table 33. North America Biomarker Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biomarker Technology Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biomarker Technology Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biomarker Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biomarker Technology Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biomarker Technology Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biomarker Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biomarker Technology Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biomarker Technology Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biomarker Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biomarker Technology Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biomarker Technology Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biomarker Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biomarker Technology Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biomarker Technology Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Laboratories Company Details
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Biomarker Technology Product
Table 51. Abbott Laboratories Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Quanterix Company Details
Table 54. Quanterix Business Overview
Table 55. Quanterix Biomarker Technology Product
Table 56. Quanterix Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 57. Quanterix Recent Development
Table 58. Bio-Rad Laboratories Company Details
Table 59. Bio-Rad Laboratories Business Overview
Table 60. Bio-Rad Laboratories Biomarker Technology Product
Table 61. Bio-Rad Laboratories Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 62. Bio-Rad Laboratories Recent Development
Table 63. Epigenomics Company Details
Table 64. Epigenomics Business Overview
Table 65. Epigenomics Biomarker Technology Product
Table 66. Epigenomics Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 67. Epigenomics Recent Development
Table 68. Agilent Technologies Company Details
Table 69. Agilent Technologies Business Overview
Table 70. Agilent Technologies Biomarker Technology Product
Table 71. Agilent Technologies Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 72. Agilent Technologies Recent Development
Table 73. Johnson & Johnson Company Details
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Biomarker Technology Product
Table 76. Johnson & Johnson Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 77. Johnson & Johnson Recent Development
Table 78. Qiagen Company Details
Table 79. Qiagen Business Overview
Table 80. Qiagen Biomarker Technology Product
Table 81. Qiagen Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 82. Qiagen Recent Development
Table 83. Roche Holding Company Details
Table 84. Roche Holding Business Overview
Table 85. Roche Holding Biomarker Technology Product
Table 86. Roche Holding Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 87. Roche Holding Recent Development
Table 88. Siemens Healthcare Company Details
Table 89. Siemens Healthcare Business Overview
Table 90. Siemens Healthcare Biomarker Technology Product
Table 91. Siemens Healthcare Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 92. Siemens Healthcare Recent Development
Table 93. Myriad Genetics Company Details
Table 94. Myriad Genetics Business Overview
Table 95. Myriad Genetics Biomarker Technology Product
Table 96. Myriad Genetics Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 97. Myriad Genetics Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Biomarker Technology Picture
Figure 2. Global Biomarker Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biomarker Technology Market Share by Type: 2024 VS 2031
Figure 4. Polymerase Chain Reaction(PCR) Features
Figure 5. Next Generation Sequencing(NGS) Features
Figure 6. Immunoassay Features
Figure 7. Others Features
Figure 8. Global Biomarker Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biomarker Technology Market Share by Application: 2024 VS 2031
Figure 10. Cancer Case Studies
Figure 11. Infectious Diseases Case Studies
Figure 12. Auoimmune Disorders Case Studies
Figure 13. Cardiovascular Disorders Case Studies
Figure 14. Others Case Studies
Figure 15. Biomarker Technology Report Years Considered
Figure 16. Global Biomarker Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Biomarker Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Biomarker Technology Market Share by Region: 2024 VS 2031
Figure 19. Global Biomarker Technology Market Share by Players in 2024
Figure 20. Global Top Biomarker Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Technology as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Biomarker Technology Revenue in 2024
Figure 22. North America Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Biomarker Technology Market Share by Country (2020-2031)
Figure 24. United States Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Biomarker Technology Market Share by Country (2020-2031)
Figure 28. Germany Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Biomarker Technology Market Share by Region (2020-2031)
Figure 36. China Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Biomarker Technology Market Share by Country (2020-2031)
Figure 44. Mexico Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Biomarker Technology Market Share by Country (2020-2031)
Figure 48. Turkey Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Abbott Laboratories Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 52. Quanterix Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 54. Epigenomics Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 55. Agilent Technologies Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 56. Johnson & Johnson Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 57. Qiagen Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 58. Roche Holding Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 59. Siemens Healthcare Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 60. Myriad Genetics Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Biomarker Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Polymerase Chain Reaction(PCR)
Table 3. Key Players of Next Generation Sequencing(NGS)
Table 4. Key Players of Immunoassay
Table 5. Key Players of Others
Table 6. Global Biomarker Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biomarker Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biomarker Technology Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biomarker Technology Market Share by Region (2020-2025)
Table 10. Global Biomarker Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biomarker Technology Market Share by Region (2026-2031)
Table 12. Biomarker Technology Market Trends
Table 13. Biomarker Technology Market Drivers
Table 14. Biomarker Technology Market Challenges
Table 15. Biomarker Technology Market Restraints
Table 16. Global Biomarker Technology Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biomarker Technology Market Share by Players (2020-2025)
Table 18. Global Top Biomarker Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Technology as of 2024)
Table 19. Ranking of Global Top Biomarker Technology Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biomarker Technology Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biomarker Technology, Headquarters and Area Served
Table 22. Global Key Players of Biomarker Technology, Product and Application
Table 23. Global Key Players of Biomarker Technology, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biomarker Technology Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biomarker Technology Revenue Market Share by Type (2020-2025)
Table 27. Global Biomarker Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biomarker Technology Revenue Market Share by Type (2026-2031)
Table 29. Global Biomarker Technology Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biomarker Technology Revenue Market Share by Application (2020-2025)
Table 31. Global Biomarker Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biomarker Technology Revenue Market Share by Application (2026-2031)
Table 33. North America Biomarker Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biomarker Technology Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biomarker Technology Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biomarker Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biomarker Technology Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biomarker Technology Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biomarker Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biomarker Technology Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biomarker Technology Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biomarker Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biomarker Technology Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biomarker Technology Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biomarker Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biomarker Technology Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biomarker Technology Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Laboratories Company Details
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Biomarker Technology Product
Table 51. Abbott Laboratories Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Quanterix Company Details
Table 54. Quanterix Business Overview
Table 55. Quanterix Biomarker Technology Product
Table 56. Quanterix Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 57. Quanterix Recent Development
Table 58. Bio-Rad Laboratories Company Details
Table 59. Bio-Rad Laboratories Business Overview
Table 60. Bio-Rad Laboratories Biomarker Technology Product
Table 61. Bio-Rad Laboratories Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 62. Bio-Rad Laboratories Recent Development
Table 63. Epigenomics Company Details
Table 64. Epigenomics Business Overview
Table 65. Epigenomics Biomarker Technology Product
Table 66. Epigenomics Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 67. Epigenomics Recent Development
Table 68. Agilent Technologies Company Details
Table 69. Agilent Technologies Business Overview
Table 70. Agilent Technologies Biomarker Technology Product
Table 71. Agilent Technologies Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 72. Agilent Technologies Recent Development
Table 73. Johnson & Johnson Company Details
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Biomarker Technology Product
Table 76. Johnson & Johnson Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 77. Johnson & Johnson Recent Development
Table 78. Qiagen Company Details
Table 79. Qiagen Business Overview
Table 80. Qiagen Biomarker Technology Product
Table 81. Qiagen Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 82. Qiagen Recent Development
Table 83. Roche Holding Company Details
Table 84. Roche Holding Business Overview
Table 85. Roche Holding Biomarker Technology Product
Table 86. Roche Holding Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 87. Roche Holding Recent Development
Table 88. Siemens Healthcare Company Details
Table 89. Siemens Healthcare Business Overview
Table 90. Siemens Healthcare Biomarker Technology Product
Table 91. Siemens Healthcare Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 92. Siemens Healthcare Recent Development
Table 93. Myriad Genetics Company Details
Table 94. Myriad Genetics Business Overview
Table 95. Myriad Genetics Biomarker Technology Product
Table 96. Myriad Genetics Revenue in Biomarker Technology Business (2020-2025) & (US$ Million)
Table 97. Myriad Genetics Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Biomarker Technology Picture
Figure 2. Global Biomarker Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biomarker Technology Market Share by Type: 2024 VS 2031
Figure 4. Polymerase Chain Reaction(PCR) Features
Figure 5. Next Generation Sequencing(NGS) Features
Figure 6. Immunoassay Features
Figure 7. Others Features
Figure 8. Global Biomarker Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biomarker Technology Market Share by Application: 2024 VS 2031
Figure 10. Cancer Case Studies
Figure 11. Infectious Diseases Case Studies
Figure 12. Auoimmune Disorders Case Studies
Figure 13. Cardiovascular Disorders Case Studies
Figure 14. Others Case Studies
Figure 15. Biomarker Technology Report Years Considered
Figure 16. Global Biomarker Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Biomarker Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Biomarker Technology Market Share by Region: 2024 VS 2031
Figure 19. Global Biomarker Technology Market Share by Players in 2024
Figure 20. Global Top Biomarker Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Technology as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Biomarker Technology Revenue in 2024
Figure 22. North America Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Biomarker Technology Market Share by Country (2020-2031)
Figure 24. United States Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Biomarker Technology Market Share by Country (2020-2031)
Figure 28. Germany Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Biomarker Technology Market Share by Region (2020-2031)
Figure 36. China Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Biomarker Technology Market Share by Country (2020-2031)
Figure 44. Mexico Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Biomarker Technology Market Share by Country (2020-2031)
Figure 48. Turkey Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Biomarker Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Abbott Laboratories Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 52. Quanterix Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 54. Epigenomics Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 55. Agilent Technologies Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 56. Johnson & Johnson Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 57. Qiagen Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 58. Roche Holding Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 59. Siemens Healthcare Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 60. Myriad Genetics Revenue Growth Rate in Biomarker Technology Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Double-handle Kitchen Mixer Tap Market Research Report 2025
Jul 24, 25
Global Kitchen Mixer Tap Market Research Report 2025
Jul 24, 25
Global Kitchen Collection Market Research Report 2025
Jul 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232